Welcome to our dedicated page for Univ Health Svc SEC filings (Ticker: UHS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Medicare reimbursement tables, patient-day counts, and behavioral health margins scatter across hundreds of pages in Universal Health Services� disclosures—finding them is a real challenge. If you have ever asked, “Where can I see UHS’s payer mix breakdown?� or “How do I track Universal Health Services insider trading Form 4 transactions?�, you know the pain of combing through technical exhibits.
Stock Titan solves this complexity. Our platform streams every UHS filing from EDGAR the moment it posts and layers AI-powered summaries that explain the implications in plain language. Whether you need the UHS quarterly earnings report 10-Q filing, a freshly issued 8-K material events explained, or the full Universal Health Services annual report 10-K simplified, we highlight the sections that matter—reimbursement risk, malpractice reserves, occupancy trends, and acquisition costs—so you can focus on decisions, not page counts.
Navigate filings the way professionals do:
- One-click access to UHS Form 4 insider transactions real-time and alerts on UHS executive stock transactions Form 4
- Clear dashboards comparing service-line revenue across quarters with our Universal Health Services earnings report filing analysis
- Concise overviews of director pay and governance inside every UHS proxy statement executive compensation
- Contextual summaries that make UHS SEC filings explained simply—ideal for analysts, clinicians, or credit desks
Stop scrolling through PDFs. With Stock Titan you get understanding UHS SEC documents with AI, real-time updates, and the depth healthcare investors require—all in one intuitive space.
Universal Health Services reported stronger operating results for the quarter and first half of 2025. Net revenues for the three months ended June 30, 2025 were $4.284 billion versus $3.908 billion a year earlier, and net income attributable to UHS was $353.2 million versus $289.2 million, producing basic EPS of $5.49 compared with $4.32 a year ago. For the six months, revenues were $8.384 billion and net income attributable to UHS was $669.9 million, with diluted EPS of $10.23 versus $8.08 in the prior year period.
The balance sheet shows total assets of $14.986 billion and total equity of $7.086 billion at June 30, 2025. Net cash provided by operating activities for the six months was $909.0 million; investing included $505.0 million of capital expenditures; financing used $319.1 million, including $378.5 million of share repurchases and $26.4 million of dividends. Self-insured reserves remain significant ($487 million professional/general liability; $147 million workers� compensation), and the company disclosed ongoing legal matters including the Cumberland litigation and a confidential settlement that vacated a prior judgment for The Pavilion.